| ²é¿´: 232 | »Ø¸´: 3 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
li2009ľ³æ (СÓÐÃûÆø)
|
[½»Á÷]
Âé·³¡°monitor2885¡±ÔÙ·ÒëÊ£ÓàµÄ2¶Î£¡XIE XIE
|
||
|
ÓÉÓÚAÐÂÖÆ¼Á·ÀÖÎÇÝÁ÷¸ÐЧ¹ûÏÔÖø£¬Ó¡¶ÈÄáÎ÷ÑÇ¡¢Ô½ÄÏ¡¢Ì©¹úµÈ½üÄêÀ´Æµ·±·¢ÉúÇÝÁ÷¸ÐÒßÇéµÄ¹ú¼Ò£¬Í¨¹ý²»Í¬ÇþµÀ´ÓÑо¿¿ÎÌâ×é¶©¹ºA£¬¹úÄÚµÄÐí¶à´óÐÍÇÝÀàÑøÖ³³¡Ò²·×·×¶©¹º£¬ÔÚ·ÀÖÎÇÝÁ÷¸Ð·½Ãæ·¢»ÓÁËÖØÒªµÄ×÷ÓᣠL˵£¬Ä¿Ç°£¬¿¹²¡¶¾µÄÒ©Îï·Ç³£ÉÙ£¬AµÄ¿¹²¡¶¾Ð§¹ûÊÇÒ»°ã¿¹²¡¶¾Ò©Ëù²»¾ß±¸µÄ£¬ÔÚÇÝÁ÷¸Ð·ÀÖη½ÃæµÄÒ©ÓüÛÖµÒѵõ½³ä·ÖÑéÖ¤¡£ÓÉÓÚÁ÷¸Ð²¡¶¾µÄ±äÒìÐÔºÜÇ¿£¬±»¹ã·ºÊ¹ÓõÄÒßÃçÒѾ²»ÄÜÍêÈ«½â¾ö´«È¾²¡Ô¤·À£¬ÕâÒ»ÐÎÊÆ¸øÑз¢AÒ»ÀàµÄ¿¹²¡¶¾ÖÐÒ©ÌṩÁË»úÓö¡£´Ó£²£°£°7ÄêÆð£¬¿ÆÑÐÈËÔ±ÀûÓÃÖпÆÔº¡°°ÙÈ˼ƻ®¡±µÄ×ÊÖú¾·Ñ£¬¿ªÕ¹ÁËA·ÀÖÎÈËÁ÷¸ÐµÄÑо¿£¬Ñ¡ÔñµÄÕýºÃÊǼ×Ðͣȣ±£Î£±Á÷¸Ð²¡¶¾¡£ ÓÉÓÚÐÂÒ©µÄ»ù´¡Ñо¿¡¢ÁÙ´²Ç°Ñо¿¡¢ÁÙ´²Ñо¿¡¢ÐÂÒ©É걨ºÍÉóÅú³ÌÐò¸´ÔÓ£¬ÎªÁËÔçÈÕ·¢»ÓAÔÚÁ÷¸Ð·ÀÖεȷ½ÃæµÄ¿¹²¡¶¾×÷Ó㬣²£°£°£¸ÄꣵÔ£¬ÔÚ±¨G±¸°¸ºó£¬JºÍGºÏ×÷£¬¿ªÊ¼Éú²ú¹áÒ¶Á¬ÇÌ£¨Ö÷Òª³É·ÖÊÇA£©Ãâ¼åÒûƬ£¨Ðí¿ÉÖ¤ºÅ£º¸ÊY20030045£©£¬²úÆ·ÒÑÔÚGµØÇøÓ¦Óã¬ÔÚÈËÁ÷¸ÐµÄÖÎÁÆÉÏÈ¡µÃÁ˽ϺõÄЧ¹û¡£ |
» ²ÂÄãϲ»¶
085600 286·Ö ²ÄÁÏÇóµ÷¼Á
ÒѾÓÐ11È˻ظ´
Ò»Ö¾Ô¸ºÓ±±¹¤Òµ´óѧ0817»¯¹¤278·ÖÇóµ÷¼Á
ÒѾÓÐ15È˻ظ´
085601²ÄÁϹ¤³ÌÕÒµ÷¼Á
ÒѾÓÐ15È˻ظ´
²ÄÁÏÓ뻯¹¤272Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
ÄϾ©´óѧ»¯Ñ§µ÷¼Á
ÒѾÓÐ14È˻ظ´
Ò»Ö¾Ô¸±±¾©¹¤Òµ´óѧ£¬324·ÖÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
281Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
26É격×Ô¼ö
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸¹þ¶û±õ¹¤Òµ´óѧ²ÄÁÏÓ뻯¹¤·½Ïò336·Ö
ÒѾÓÐ10È˻ظ´
monitor2885
ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)
¶Ó³¤
- ·ÒëEPI: 15
- Ó¦Öú: 6 (Ó×¶ùÔ°)
- ¹ó±ö: 0.339
- ½ð±Ò: 39449.5
- É¢½ð: 147
- ºì»¨: 22
- Ìû×Ó: 4992
- ÔÚÏß: 2172.8Сʱ
- ³æºÅ: 701577
- ×¢²á: 2009-02-15
- ÐÔ±ð: GG
- רҵ: Éú̬ϵͳÉú̬ѧ
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
li2009(½ð±Ò+20,VIP+0):´óϺ Ó¢ÓïÕæ°ô£¡ 8-21 09:29
li2009(½ð±Ò+20,VIP+0):´óϺ Ó¢ÓïÕæ°ô£¡ 8-21 09:29
|
ÓÉÓÚÐÂÒ©µÄ»ù´¡Ñо¿¡¢ÁÙ´²Ç°Ñо¿¡¢ÁÙ´²Ñо¿¡¢ÐÂÒ©É걨ºÍÉóÅú³ÌÐò¸´ÔÓ£¬ÎªÁËÔçÈÕ·¢»ÓAÔÚÁ÷¸Ð·ÀÖεȷ½ÃæµÄ¿¹²¡¶¾×÷Ó㬣²£°£°£¸ÄꣵÔ£¬ÔÚ±¨G±¸°¸ºó£¬JºÍGºÏ×÷£¬¿ªÊ¼Éú²ú¹áÒ¶Á¬ÇÌ£¨Ö÷Òª³É·ÖÊÇA£©Ãâ¼åÒûƬ£¨Ðí¿ÉÖ¤ºÅ£º¸ÊY20030045£©£¬²úÆ·ÒÑÔÚGµØÇøÓ¦Óã¬ÔÚÈËÁ÷¸ÐµÄÖÎÁÆÉÏÈ¡µÃÁ˽ϺõÄЧ¹û¡£ For some drawbacks, namely basic research of new drug, preclinical research, clinical research, reporting and approval, an effective task should be completed in order to early realize antiviral activity of A in prevention and treatment of influenza. On May 2008, after reporting to G, J and G initiated co-operation to produce free-fried piece of Hypericum perforatum (mainly constituent: A, license number: Gan Y20030045). The products have been applied in G region, and excellent effects in treatment of human influenza were found. |

4Â¥2009-08-20 20:45:33
monitor2885
ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)
¶Ó³¤
- ·ÒëEPI: 15
- Ó¦Öú: 6 (Ó×¶ùÔ°)
- ¹ó±ö: 0.339
- ½ð±Ò: 39449.5
- É¢½ð: 147
- ºì»¨: 22
- Ìû×Ó: 4992
- ÔÚÏß: 2172.8Сʱ
- ³æºÅ: 701577
- ×¢²á: 2009-02-15
- ÐÔ±ð: GG
- רҵ: Éú̬ϵͳÉú̬ѧ
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
li2009(½ð±Ò+15,VIP+0):лл ´óϺ£¡ 8-21 09:25
li2009(½ð±Ò+15,VIP+0):лл ´óϺ£¡ 8-21 09:25
|
ÓÉÓÚAÐÂÖÆ¼Á·ÀÖÎÇÝÁ÷¸ÐЧ¹ûÏÔÖø£¬Ó¡¶ÈÄáÎ÷ÑÇ¡¢Ô½ÄÏ¡¢Ì©¹úµÈ½üÄêÀ´Æµ·±·¢ÉúÇÝÁ÷¸ÐÒßÇéµÄ¹ú¼Ò£¬Í¨¹ý²»Í¬ÇþµÀ´ÓÑо¿¿ÎÌâ×é¶©¹ºA£¬¹úÄÚµÄÐí¶à´óÐÍÇÝÀàÑøÖ³³¡Ò²·×·×¶©¹º£¬ÔÚ·ÀÖÎÇÝÁ÷¸Ð·½Ãæ·¢»ÓÁËÖØÒªµÄ×÷ÓᣠAs a result of remarkable effect of new agent A, some countries frequently suffered from bird flu such as Indonesia, Vietnam and Thailand in recent years, have ordered A from Research Group through various channels, as well as many domestic large poultry farms as A has played an important role in prevention and treatment for Avian influenza. |

2Â¥2009-08-20 20:27:04
monitor2885
ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)
¶Ó³¤
- ·ÒëEPI: 15
- Ó¦Öú: 6 (Ó×¶ùÔ°)
- ¹ó±ö: 0.339
- ½ð±Ò: 39449.5
- É¢½ð: 147
- ºì»¨: 22
- Ìû×Ó: 4992
- ÔÚÏß: 2172.8Сʱ
- ³æºÅ: 701577
- ×¢²á: 2009-02-15
- ÐÔ±ð: GG
- רҵ: Éú̬ϵͳÉú̬ѧ
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
li2009(½ð±Ò+15,VIP+0):лл ´óÏÀ£¡ 8-21 09:25
li2009(½ð±Ò+15,VIP+0):лл ´óÏÀ£¡ 8-21 09:25
|
L˵£¬Ä¿Ç°£¬¿¹²¡¶¾µÄÒ©Îï·Ç³£ÉÙ£¬AµÄ¿¹²¡¶¾Ð§¹ûÊÇÒ»°ã¿¹²¡¶¾Ò©Ëù²»¾ß±¸µÄ£¬ÔÚÇÝÁ÷¸Ð·ÀÖη½ÃæµÄÒ©ÓüÛÖµÒѵõ½³ä·ÖÑéÖ¤¡£ÓÉÓÚÁ÷¸Ð²¡¶¾µÄ±äÒìÐÔºÜÇ¿£¬±»¹ã·ºÊ¹ÓõÄÒßÃçÒѾ²»ÄÜÍêÈ«½â¾ö´«È¾²¡Ô¤·À£¬ÕâÒ»ÐÎÊÆ¸øÑз¢AÒ»ÀàµÄ¿¹²¡¶¾ÖÐÒ©ÌṩÁË»úÓö¡£´Ó£²£°£°7ÄêÆð£¬¿ÆÑÐÈËÔ±ÀûÓÃÖпÆÔº¡°°ÙÈ˼ƻ®¡±µÄ×ÊÖú¾·Ñ£¬¿ªÕ¹ÁËA·ÀÖÎÈËÁ÷¸ÐµÄÑо¿£¬Ñ¡ÔñµÄÕýºÃÊǼ×Ðͣȣ±£Î£±Á÷¸Ð²¡¶¾¡£ L said that at present the number of anti-viral drugs is limited, which has more excellent anti-viral effect than counterparts and the medicinal value in aspects of avian flu prevention has been verified. Due to highly variant of influenza viruses, bacterin that was widely used failed to prevent infectious diseases. Fortunately, this situation provided an opportunity to develop anti-virus medicine such as A. Since 2007, researchers using the subsidy funds of "Hundred Talents Program" of Chinese Academy of Sciences have carried out prevention influenza under A for human and influenza virus H1N1 was chosen exactly to be the aim. |

3Â¥2009-08-20 20:27:58














»Ø¸´´ËÂ¥